The three pillars of Medigrowth’s world-class offering
From seed to solution. We’re committed to becoming a global leader and valuable supply chain partners for superior medicinal cannabis extraction, laboratory testing, formulation, cultivation and innovation.
01
GROWTH AND DISTRIBUTION
In our mission to advance research and development, and application of medicinal cannabis, Medigrowth is committed to world-class cGMP design. Ongoing plant science research and Deakin University collaboration remains paramount to our long term vision for plant based alternatives, backed by science.
As the industry continues to evolve, its growth is enhanced by Medigrowth’s exclusive partnership agreements and the Medigrowth Cultivation Partner Program; the latter offers access to a comprehensive genetics catalogue for distribution throughout Australia and New Zealand.
—
If you’re a licensed or license-pending medicinal cannabis cultivator seeking more information about genetics supply or other Medigrowth services, please reach out to our team.
02
EXTRACTION AND DEVELOPMENT
In our forthcoming world-class, Australian-based manufacturing and extraction centre, the Medigrowth Centre of Excellence will continue to model and evolve best-in-class standards for design and innovation, as well as leading global extraction technologies.
Medigrowth extraction services will include: crude oil, refined oil and white labelling.
Our manufacturing and extraction centre will be a hub of valuable research and development in collaboration with Deakin University; an engine of progress that will power the continued advancement of medicinal cannabis research.
—
Medigrowth is currently inviting expressions from licensed or license-pending Australian medicinal cannabis cultivators to join our Cultivation Partner Program.
03
TESTING AND DATA
All Medigrowth products are Australian made and manufactured under AU GMP certification. Alongside extraction and manufacturing, the Medigrowth Centre of Excellence is designed to incorporate independent third-party testing services within a purpose designed, world-class GMP laboratory for all contract processing services and licenced cultivators alongside university and commercial research projects.
The Therapeutic Goods Administration (TGO 93) sets the quality requirements for medicinal cannabis compliance.
Medigrowth’s state-of-the-art lab design allows for specialised analytical testing for medicinal cannabis conforming to standards set by the Therapeutic Goods Administration, Therapeutics Goods Order 93 (TGO 93) for: metals, pesticides, terpenes, microbials, residual solvents and cannabinoid profiles.
—
If you’re a license or license-pending medicinal cannabis cultivator seeking more information about Medigrowth services, please reach out to our friendly team.
PARTNER WITH MEDIGROWTH
If you’re a license or license-pending medicinal cannabis cultivator seeking more information about genetics supply or other Medigrowth services, please reach out to our team.